JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141025

Bexarotene, RXR agonist

Be the first to review this product! Submit a review

|

(3 Publications)

MW 348.48 g/mol, Purity >99%. Potent RXR agonist (Ki values are 30.5, 16.4, 19.7, >1000 for RXRα, RXRβ, RXRγ and RAR respectively). Inhibits neurodegeneration and displays anticancer activity in vivo and in vitro. Blood-brain barrier permeable.
1 Images
Chemical Structure - Bexarotene, RXR agonist (AB141025)
  • Chemical Structure

Lab

Chemical Structure - Bexarotene, RXR agonist (AB141025)

2D chemical structure image of ab141025, Bexarotene, RXR agonist

Key facts

CAS number

153559-49-0

Purity

>99%

Form

Solid

form

Molecular weight

348.48 g/mol

Molecular formula

C<sub>2</sub><sub>4</sub>H<sub>2</sub><sub>8</sub>O<sub>2</sub>

Nature

Synthetic

Solubility

Soluble in ethanol to 25 mM

Soluble in DMSO to 50 mM

Biological description

Potent RXR agonist (Ki values are 30.5, 16.4, 19.7, >1000 for RXRα, RXRβ, RXRγ and RAR respectively). Inhibits neurodegeneration and displays anticancer activity in vivo and in vitro. Blood-brain barrier permeable.

Canonical smiles

O=C(O)C1CCC(CC1)C(=C)C2CC3C(CC2C)C(C)(C)CCC3(C)C

InChi

InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)

InChiKey

NAVMQTYZDKMPEU-UHFFFAOYSA-N

IUPAC Name

4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark|Store under desiccating conditions

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Brain pathology (Zurich, Switzerland) 33:e13126 PubMed36271611

2022

Brain-specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injury.

Applications

Unspecified application

Species

Unspecified reactive species

Heng Xu,Le-Xin Zheng,Xue-Shi Chen,Qiu-Yu Pang,Ya-Nan Yan,Rong Liu,Han-Mu Guo,Zhi-Yang Ren,Yan Yang,Zhi-Ya Gu,Cheng Gao,Yuan Gao,Cheng-Liang Luo,Ying Zhao,Ying Wang,Tao Wang,Lu-Yang Tao

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 30:585-594 PubMed35693438

2022

iTRAQ-derived quantitative proteomics uncovers the neuroprotective property of bexarotene in a mice model of cerebral ischemia-reperfusion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Hailin Liu,Hu Wang,Sisi Chen,Shengwei Liu,Xiaocui Tian,Zhi Dong,Lu Xu

Neurochemical research 44:2809-2820 PubMed31680194

2019

Bexarotene Attenuates Focal Cerebral Ischemia-Reperfusion Injury via the Suppression of JNK/Caspase-3 Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hailin Liu,Shengwei Liu,Xiaocui Tian,Qian Wang,Jiangyan Rao,Yucun Wang,Fei Xiang,Hang Zheng,Lu Xu,Zhi Dong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com